← Back to headlines
Clawback Policy Hinders Pharmaceutical Development in Greece
Relations between the Greek Ministry of Health and multinational pharmaceutical companies are at an impasse due to exorbitant mandatory clawback payments on hospital drugs and proposed legislative changes that are expected to exacerbate the issue.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
